It uses antibodies conjugated with heavy metals rather than fluorochromes to label cells expressing proteins of interest, followed by time-of-flight (TOF) mass spectrometry for detection. The advantages include significantly enhanced multiplexing without the need for compensation between channels.
The Single Cell Imaging and Mass Cytometry Analysis Platform (SCIMAP) provides researchers with access to the latest and most advanced technologies in spatial biology and single-cell analysis. Our state-of-the-art tools are designed to meet the diverse and evolving needs of the research community, enabling groundbreaking discoveries in a wide range of fields, including cancer biology, neuroscience, immunology, and developmental biology. Below, you’ll find a list of the key technologies we offer, each equipped with specialized capabilities to support your research goals.
Why Choose SCIMAP?
At SCIMAP, we don’t just provide access to advanced technologies, we offer comprehensive support throughout your research journey. From expert consultation on experimental design to personalized data analysis and interpretation, our team is committed to helping you make the most of the tools we offer. Whether you are exploring new frontiers in spatial biology or delving deep into single-cell dynamics, SCIMAP is here to support your research every step of the way.
Core Manager |
Scientific Director |
Core Directors |
Fluorescence Slide Scanner
Instrument |
Description |
Unit |
Internal
|
Academia |
Axio Scan.Z1* |
Brightfield | slide (20x) | $4.00 - $10.00 |
$12.00 |
slide (40x) | $8.00 - $20.00 |
$24.00 |
||
Fluorescence |
slide (20x) |
$12.00 |
$24.00 |
|
slide (40x) |
$24.00 |
$48.00 |
Mass Cytometry
Instrument |
Description |
Unit |
Internal
|
Academia |
Helios | Cell suspension | hour
|
$75.00 |
$75.00 |
Hyperion | Tissue |
hour |
$100.00 |
$100.00 |
Metal-labelled antibodies | ul |
$4.00 - $8.00 |
$4.00 - $8.00 |
LSC* - Life Sciences Complex, McGill University
The Xenium platform by 10x Genomics offers an advanced, end-to-end solution for spatial gene expression profiling at subcellular resolution. This powerful tool allows researchers to map and quantify up to 5,000 genes within their spatial context, providing insights into cellular functions and interactions that were previously unattainable. The platform is compatible with both fresh frozen (FF) and formalin-fixed, paraffin-embedded (FFPE) tissues, making it versatile for various research needs.
Xenium's unique probe chemistry ensures high specificity, enabling precise localization of RNA molecules within tissue sections. The platform also supports future capabilities for multiplexed protein detection, allowing simultaneous RNA and protein analysis on the same tissue section. With its non-destructive workflow, researchers can retain tissue morphology for subsequent staining, such as H&E or immunofluorescence, facilitating direct comparisons between transcriptional data and morphological features. The Xenium Analyzer, a robust and versatile instrument, automates the entire process from sample preparation to data analysis, delivering high-resolution images and detailed gene expression maps that can be visualized and explored using Xenium Explorer or other compatible tools.
The Visium HD (Cytassist) platform from 10x Genomics provides high-definition spatial transcriptomics, enabling researchers to perform whole-transcriptome analysis with single-cell scale resolution. This platform uniquely combines histology with spatially resolved gene expression profiling, allowing for the detailed localization and quantification of gene expression within the tissue context.
Visium HD uses a redesigned slide architecture featuring millions of 2x2 µm barcoded squares, ensuring continuous tissue coverage without gaps. This design facilitates the high-resolution mapping of gene expression across entire tissue sections, making it an ideal tool for studies requiring precise spatial information, such as in cancer biology, neuroscience, and developmental biology. The Cytassist instrument further enhances the Visium workflow by enabling the transfer of transcriptomic probes from standard glass slides to Visium slides, thus broadening the range of sample types that can be analyzed. Visium HD's streamlined workflow and advanced imaging capabilities make it an essential platform for researchers looking to explore the intricate spatial organization of tissues with unparalleled clarity.
Helios is the third-generation mass cytometer (CyTOF) produced by Fluidigm, designed for in-depth phenotypic analysis of single cells using inductively coupled plasma time-of-flight mass spectrometry (ICP-MS). Helios allows for the simultaneous analysis of more than 40 markers on a single cell, enabling researchers to capture a tremendous amount of data from minimal sample sizes. This technology is ideal for generating high-dimensional single-cell datasets, providing unparalleled insight into cellular diversity and function.
The Hyperion by Fluidigm offers imaging mass cytometry, a complementary technology to flow-based mass cytometry that allows for the spatial analysis of tissue samples stained with metal-conjugated antibodies. Hyperion achieves single-cell resolution by scanning tissue sections with a small-spot-size pulsed laser, vaporizing 1-micron spots with each laser shot, and analyzing them using mass cytometry. This approach allows for the mapping of target proteins throughout the tissue section, preserving spatial localization and enabling the digital reconstruction of tissues. Researchers can interrogate tissues with over 40 parameters simultaneously, providing rich datasets that combine protein expression and spatial localization within an intact tissue sample.
The Chromium X platform by 10x Genomics is a revolutionary tool for single-cell and multiomic analysis, offering unmatched resolution, sensitivity, and throughput. Utilizing advanced GEM-X technology, it enables precise partitioning and barcoding of up to 20,000 cells per channel, allowing comprehensive profiling of transcriptomes, chromatin accessibility, and cell surface proteins in a single experiment. Its multiomic capabilities, combined with optimized workflows and scalable flexibility, make it suitable for a wide range of applications, from oncology and neuroscience to immunology and drug discovery. The platform is tissue- and species-agnostic, ensuring consistent, high-quality results across diverse research needs, while intuitive software tools facilitate in-depth data analysis and visualization. Chromium X empowers researchers to explore cellular complexity at an unprecedented scale, driving breakthroughs in biomedical research.